ACAT1 is the major enzyme that catalyzes the synthesis of cholesteryl esters in CD8+ T cells, and pharmacological or genetic inhibition of ACAT1 increases intracellular cholesterol levels in melanoma tumor-infiltrating T lymphocytes (TIL), thereby inducing a superior immune response (219). This evidence concerns the gene ACAT1 and melanoma.